Spending on NHS attention deficit hyperactivity disorder (ADHD) and autism services in England has surged out of control, according to the NHS Alliance, with some local health areas reporting cost increases of up to tenfold over a single year. Health managers warn that soaring demand following the coronavirus pandemic is destabilizing budgets, forcing some integrated care boards (ICBs) to close waiting lists or scale back other healthcare provisions.
Soaring Costs and Exploding Budgets Across England
Local health systems are facing unprecedented financial strain as demand for neurodivergent assessments outpaces capacity. According to the NHS Alliance report, one ICB watched its monthly spend jump from £146,000 in the 2024-25 period to £1.5m last year. Another ICB reported that its annual expenditure on adult ADHD services climbed from £11m in 2023-24 to a projected £51m for the current financial year.
Rebecca Gray, the director of the NHS Alliance’s mental health network, described the impossible position facing commissioners. “Local health leaders are caught between a rock and a hard place,” Gray stated, noting that leaders fully understand patient anguish over long delays but must contend with runaway costs that disrupt long-term planning and impact other services.
The Right to Choose and the Influx of Providers
A major driver behind the spending spike is the patient’s right to choose, which allows individuals seeking a diagnosis for themselves or their children to opt for any qualified provider. With NHS capacity severely restricted, this mechanism triggered a massive influx of providers entering the market.
The report highlights significant variations in market saturation across different regions. One ICB told the NHS Alliance it now deals with 80 separate providers on its patch. Another reported that its active vendor count surged from roughly 12 to 14 providers up to 48 within a two-year window.
Did You Know? Due to the absence of a national pricing framework or tariff for these services, ICBs reported paying wildly disparate rates—anywhere from £300 to £3,000—for nearly identical ADHD and autism assessments.
Regulatory Concerns and Quality Assurance Risks
The rapid expansion of the provider market has raised alarms among health managers regarding quality oversight. Many of the newly arrived operators are small, non-regulated entities capable of delivering diagnostic assessments but lacking the infrastructure to provide ongoing post-diagnostic care and medical treatment.
While the expanded capacity has successfully clipped waiting times in certain regions, the lack of standardized pricing and regulatory guardrails has exacerbated severe fiscal deficits. The NHS Alliance argues that the current ecosystem produces an unfavorable outcome for taxpayers and patients alike, threatening the financial viability of local health economies.
Proposed Solutions: National Tariffs and Standardization
To rein in unmanaged expenditures, the NHS Alliance is pushing for structural reforms at the national level. The organization is calling for the implementation of a mandatory national price, or tariff, alongside a uniform service specification applied consistently across every NHS-funded provider.
Without centralized price controls and standardized quality thresholds, health leaders warn that unexpected overspends will continue to compromise broader regional healthcare delivery.
Frequently Asked Questions
Why are NHS costs for ADHD and autism services rising so sharply?
Costs are surging due to a post-pandemic spike in demand combined with limited internal NHS capacity, leading patients to exercise their right to choose alternative qualified providers. The lack of a national pricing tariff has resulted in extreme price variations among private vendors.
How much are ICBs spending on these services?
Spending increases vary by region, with one ICB reporting a monthly spend increase from £146,000 to £1.5m, and another projecting adult ADHD spending to rise from £11m to £51m in a single financial year.
What solutions are health leaders proposing?
The NHS Alliance is calling on authorities to establish a mandatory national price tariff and a consistent national service specification for all NHS-funded ADHD and autism providers.
Stay Informed on NHS Policy Changes
Sign up for our daily newsletter to get the latest updates on public health funding, policy shifts, and healthcare management developments delivered straight to your inbox.
Worth a look